Rhythm Pharmaceuticals - 48 Year Dividend History | RYTM

Historical dividend payout and yield for Rhythm Pharmaceuticals (RYTM) since 1971. The current TTM dividend payout for Rhythm Pharmaceuticals (RYTM) as of June 19, 2019 is $0.00. The current dividend yield for Rhythm Pharmaceuticals as of June 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.790B $0.000B
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies which result in life-threatening metabolic disorders. The Company's product candidate principally consists of setmelanotide, a potent, first-in-class melanocortin-4 receptor or MC4R, agonist for the treatment of rare genetic disorders of obesity. Rhythm Pharmaceuticals, Inc. is based in Boston, MA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $111.478B 12.60
Gilead Sciences (GILD) United States $87.024B 10.57
Bio-Techne Corp (TECH) United States $7.996B 54.56